Elevated cytokine and nitric oxide levels in Behçet disease: EBI-3 as a potential biomarker of vascular involvement
Immunology Letters · 2026-10 · 281 · 107188
DOI: 10.1016/j.imlet.2026.107188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2026-10. Verfasst von Nourelhouda Ghozali und 12 weiteren Autor:innen. Beteiligte Einrichtung: Team "Cytokines and NO synthases: Immunity and pathogenesis", LBCM, FSB, USTHB, Algiers, Algeria; Laboratory of Biodiversity, Biotechnology, Environm…. Hauptthemen laut MEDLINE: Behcet Syndrome, Nitric Oxide, Biomarkers, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Behçet disease (BD) is multisystem inflammatory vasculitis affecting vessels of all types and sizes. Vascular involvement represents one of the most severe and life-threatening manifestations, associated with increased morbidity and mortality. The aim of this study was to investigate the role of cytokines and nitric oxide (NO) in the pathogenesis of BD, which could potentially highlight a new biomarker, capable of discriminating between patients with and without vascular involvement. METHODS Plasma levels of cytokines and NO were measured using ELISA and modified Griess method, respectively. Statistical analyses were performed using Mann Whitney U test and Kruskal-Wallis for group comparisons. RESULTS Our results demonstrated a significant increase in EBI-3 levels in patients with vascular involvement compared to both non-vascular patients and healthy controls (HC). Receiver operating characteristic (ROC) curve analysis revealed an area under curve (AUC) of 0.8901± 0.07705 (0.7391 to 1.000). At a cutoff value of 56.56 pg/ml, EBI-3 showed a specificity of 92.86% and a sensitivity of 84.62% (P = 0.0006). In contrast, NO, IL-6 and IL-32 levels were significantly elevated in all BD clinical manifestations compared to HC. While, IL-6R, IL-10, and IL-37 showed no significant difference. CONCLUSION These findings highlight the potential involvement of EBI-3 in vascular manifestations and suggest its utility as a biomarker for vascular involvement of BD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Team "Cytokines and NO synthases: Immunity and pathogenesis", LBCM, FSB, USTHB, Algiers, Algeria; Laboratory of Biodiversity, Biotechnology, Environment, and Sustainable Development, FS, UMBB, Boumerdes, Algeria.
- Team "Cytokines and NO synthases: Immunity and pathogenesis", LBCM, FSB, USTHB, Algiers, Algeria.
- Central laboratory, CHU Nafissa Hammoud, Algiers, Algeria.
- Department of neurology, CHU Mustapha Bacha, Algiers, Algeria.
- Department of ophthalmology, CHU Nafissa Hammoud, Algiers, Algeria.
- Laboratory of Biodiversity, Biotechnology, Environment, and Sustainable Development, FS, UMBB, Boumerdes, Algeria.
Zitieren
APA
Ghozali, N., Hadjimi, Z., Abdesselam, Z., Bouzid, F., Ihammichene, S., Kediha, M. I., Terahi, M., Belkacem, H. A. A., Hakem, D., Moulay, S., Laraba, N., Touil-Boukoffa, C., & Belguendouz, H. (2026). Elevated cytokine and nitric oxide levels in Behçet disease: EBI-3 as a potential biomarker of vascular involvement. Immunology Letters, 281, 107188. https://doi.org/10.1016/j.imlet.2026.107188
Vancouver
Ghozali N, Hadjimi Z, Abdesselam Z, Bouzid F, Ihammichene S, Kediha MI, et al. Elevated cytokine and nitric oxide levels in Behçet disease: EBI-3 as a potential biomarker of vascular involvement. Immunology Letters. 2026;281:107188. doi:10.1016/j.imlet.2026.107188
BibTeX
@article{Ghozali2026,
author = {Ghozali, Nourelhouda and Hadjimi, Zohra and Abdesselam, Zahira and Bouzid, Feriel and Ihammichene, Sarah and Kediha, Mohamed Islam and Terahi, Malika and Belkacem, Habiba Amroun Ait and Hakem, Djanette and Moulay, Sakina and Laraba, Nazim and Touil-Boukoffa, Chafia and Belguendouz, Houda},
title = {Elevated cytokine and nitric oxide levels in Behçet disease: EBI-3 as a potential biomarker of vascular involvement},
journal = {Immunology Letters},
year = {2026},
volume = {281},
pages = {107188},
doi = {10.1016/j.imlet.2026.107188}
}
EUVIMED